ReadYourDNA

Pantoprazole (Protonix)

Raw research findings for this medication. Mostly single studies, not curated or confirmed robust.

About Pantoprazole

What it is

Pantoprazole is a proton pump inhibitor (PPI): it switches off the pumps in the stomach lining that release acid. It is used for heartburn and acid reflux, for stomach and duodenal ulcers, as part of the treatment that clears Helicobacter pylori, and to protect the stomach during some other treatments. It is sold as Protonix, among other names.

How genes come into it

Pantoprazole, like most PPIs, is broken down mainly by the liver enzyme CYP2C19. People with low-function copies (intermediate and poor metabolizers) keep it in the blood longer, so acid is held down more; people with the fast *17 version clear it quickly, and studies link that to lower healing and Helicobacter cure rates. CPIC and DPWG have published guidelines on CYP2C19 and pantoprazole, and the US drug label discusses poor metabolizers. A few other genes have been studied, with weaker evidence.

Published guidelines

Clinical guidelines that name a gene for Pantoprazole. They sort people into groups by the gene copies they carry.

CPIC guideline: CYP2C19. Ultrarapid Metabolizer · Rapid Metabolizer · Normal Metabolizer · Likely Intermediate Metabolizer · Intermediate Metabolizer · Likely Poor Metabolizer · Poor Metabolizer · Indeterminate. Moderate. 2021.

DPWG guideline: CYP2C19. Ultrarapid Metabolizer · Rapid Metabolizer · Normal Metabolizer · Likely Intermediate Metabolizer · Intermediate Metabolizer · Likely Poor Metabolizer · Poor Metabolizer · Indeterminate. 2011.

US FDA: CYP2C19. Likely Poor Metabolizer · Poor Metabolizer. 2018.

US FDA: CYP2C19. Likely Intermediate Metabolizer · Intermediate Metabolizer · Likely Poor Metabolizer · Poor Metabolizer. Data that Support Therapeutic Management Recommendations.

What research found

Every published finding on gene variants and Pantoprazole. Upload your DNA file to see which of these rows apply to you.

Rated evidence (3 rated variants)

PharmGKB weighs all studies of a variant and rates how strong the evidence is, from 1A (strongest) to 4.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3, CYP2C19*17: Level 1A · replicated. Metabolism/PK. 7.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*3: Level 1A · replicated. Efficacy: Helicobacter Infections, Ulcer. 6.

ABCB1 rs1045642: Level 4. Efficacy: Helicobacter Infections. 4.

Metabolism (14 findings)

Studies of how quickly the body processes this medication.

CYP2C19 CYP2C19*1, CYP2C19*17: CYP2C19 *17 is associated with increased clearance of pantoprazole in healthy individuals as compared to CYP2C19 *1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *2/*2 is associated with decreased clearance of pantoprazole in healthy individuals as compared to CYP2C19 *1/*1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *1/*2 is associated with decreased metabolism of pantoprazole in healthy individuals as compared to CYP2C19 *1/*1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *1/*2 is associated with decreased clearance of pantoprazole in healthy individuals as compared to CYP2C19 *1/*1.

Response (26 findings)

Studies of how well it worked in people carrying a variant.

ABCB1 rs1045642: Genotype AA is associated with increased response to omeprazole or pantoprazole in people with Helicobacter Infections as compared to genotypes AG + GG.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *1/*2 is associated with increased response to pantoprazole in healthy individuals as compared to CYP2C19 *1/*1.

CYP2C19 CYP2C19*1, CYP2C19*2: CYP2C19 *1/*2 is associated with increased response to omeprazole or pantoprazole in people with Helicobacter Infections as compared to CYP2C19 *1/*1.

CYP2C19 CYP2C19*1, CYP2C19*2, CYP2C19*17: CYP2C19 *1/*1 is associated with decreased response to pantoprazole in people with Helicobacter Infections as compared to CYP2C19 *1/*2 + *2/*17 + *2/*2.

Study findings and evidence levels: PharmGKB (CC BY-SA 4.0). Guidelines: CPIC and DPWG, as bundled in PharmCAT. Most studies were done mainly in people of European ancestry.

Related Drugs

More drugs from the same category

Aciphex (PPIs)

Dexilant (PPIs)

Nexium (PPIs)

Not a prescribing recommendation. This page is educational information about pharmacogenomic research and clinical guidelines - it is not medical or dosing advice, and not a prediction of how any medication will work for you. Never start, stop, or change a medication or dose based on it; talk to your doctor or pharmacist, who can order clinical-grade testing if appropriate.

Back to Medications

Content updated September 2026.

ReadYourDNA provides educational interpretation of DNA data you already have. It is not diagnostic, not a substitute for professional medical advice, diagnosis, or treatment, and is not intended to diagnose, treat, cure, or prevent any disease. Talk to a clinician before acting on any result.

Raw DNA Data Reports for 23andMe & AncestryDNA · About ReadYourDNA · FAQ · Methodology & Science · Pricing · Support and complaints · Legal & Contact · Health Traits · Pharmacogenomics · Carrier Status · Variant Explorer · The Human Karyotype · Privacy Policy · Terms of Service · Accessibility · Consumer Health Data Privacy · Your Privacy Choices · Editorial Standards · Your Data, Checkable · Sample Report · ReadYourDNA and Promethease compared · What is inside a 23andMe raw data file · What is inside an AncestryDNA raw data file · What a chatbot can and cannot do with your raw DNA file · Where a raw DNA file can still be uploaded in 2026

Written, maintained and operated by Martin Pechhacker, sole proprietor, Vienna, Austria. Trade register GISA 40064420. support@readyourdna.com